Pulmonary rehabilitation: The reference therapy for undernourished patients with chronic obstructive pulmonary disease

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Samaras, Nikolaos ^a   Samaras, Dimitrios ^a   Chambellan, Arnaud ^b   Pichard, Claude ^a   Thibault, Ronan ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b CHU de Nantes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID; OXANDROLONE; STANOZOLOL; TESTOSTERONE; TESTOSTERONE ENANTATE; TESTOSTERONE PHENYLPROPIONATE; TESTOSTERONE PROPIONATE; TESTOSTERONE UNDECANOATE;

ANDROGEN THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIET SUPPLEMENTATION; DRUG SAFETY; HUMAN; KINESIOTHERAPY; MALNUTRITION; MULTICENTER STUDY (TOPIC); MUSCLE ATROPHY; PATHOPHYSIOLOGY; PULMONARY REHABILITATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; STANDARD; SURVIVAL; TREATMENT OUTCOME; BODY COMPOSITION; ENERGY METABOLISM; EXERCISE; PATHOLOGY; PHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

BODY COMPOSITION; ENERGY METABOLISM; EXERCISE; HUMANS; MUSCULAR ATROPHY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84896112409     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/248420     Document Type: Review

References (84)

1. Kim V., Criner G. J., Chronic bronchitis and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2013 187 3 228 237
2. O'Donnell D. E., Banzett R. B., Carrieri-Kohlman V., Casaburi R., Davenport P. W., Gandevia S. C., Gelb A. F., Mahler D. A., Webb K. A., Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proceedings of the American Thoracic Society 2007 4 2 145 168 2-s2.0-34248353966 10.1513/pats.200611-159CC (Pubitemid 46743309)
3. O'Donnell D. E., Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2006 3 2 180 184 2-s2.0-33645526100 10.1513/pats.200508-093DO
4. Pitta F., Troosters T., Spruit M. A., Probst V. S., Decramer M., Gosselink R., Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2005 171 9 972 977 2-s2.0-18144389043 10.1164/rccm.200407-855OC (Pubitemid 40616945)
5. Barnes P. J., Celli B. R., Systemic manifestations and comorbidities of COPD. European Respiratory Journal 2009 33 5 1165 1185 2-s2.0-66749141807 10.1183/09031936.00128008
6. Evans W. J., Morley J. E., Argilés J., Bales C., Baracos V., Guttridge D., Jatoi A., Kalantar-Zadeh K., Lochs H., Mantovani G., Marks D., Mitch W. E., Muscaritoli M., Najand A., Ponikowski P., Rossi Fanelli F., Schambelan M., Schols A., Schuster M., Thomas D., Wolfe R., Anker S. D., Cachexia: a new definition. Clinical Nutrition 2008 27 6 793 799 2-s2.0-55749085001 10.1016/j.clnu.2008.06.013
7. Creutzberg E. C., Schols A. M. W. J., Bothmer-Quaedvlieg F. C. M., Wouters E. F. M., Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function. European Journal of Clinical Nutrition 1998 52 6 396 401 2-s2.0-0031749317 (Pubitemid 28284776)
8. Schols A. M. W. J., Soeters P. B., Dingemans A. M. C., Mostert R., Frantzen P. J., Wouters E. F. M., Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. American Review of Respiratory Disease 1993 147 5 1151 1156 2-s2.0-0027287584 (Pubitemid 23149871)
9. Engelen M. P. K. J., Schols A. M. W. J., Baken W. C., Wesseling G. J., Wouters E. F. M., Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. European Respiratory Journal 1994 7 10 1793 1797 2-s2.0-0028143215 10.1183/09031936.94. 07101793 (Pubitemid 24337350)
10. Engelen M. P. K. J., Schols A. M. W. J., Lamers R. J. S., Wouters E. F. M., Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clinical Nutrition 1999 18 5 275 280 2-s2.0-0032702784 10.1016/S0261-5614(98)80024-1 (Pubitemid 29527736)
11. Lewis M. I., Fournier M., Storer T. W., Bhasin S., Porszasz J., Ren S.-G., Da X., Casaburi R., Skeletal muscle adaptations to testosterone and resistance training in men with COPD. Journal of Applied Physiology 2007 103 4 1299 1310 2-s2.0-35348965646 10.1152/japplphysiol.00150.2007 (Pubitemid 47605967)
12. van Remoortel H., Hornikx M., Demeyer H., Daily physical activity in subjects with newly diagnosed COPD. Thorax 2013 68 10 962 963
13. Palange P., Forte S., Felli A., Galassetti P., Serra P., Carlone S., Nutritional state and exercise tolerance in patients with COPD. Chest 1995 107 5 1206 1212 2-s2.0-0029063454
14. Nishimura Y., Tsutsumi M., Nakata H., Tsunenari T., Maeda H., Yokoyama M., Relationship between respiratory muscle strength and lean body mass in men with COPD. Chest 1995 107 5 1232 1236 2-s2.0-0029042972
15. Thibault R., Le Gallic E., Picard-Kossovsky M., Darmaun D., Chambellan A., Assessment of nutritional status and body composition in patients with COPD: comparison of several methods. Revue des Maladies Respiratoires 2010 27 7 693 702 2-s2.0-78049275280 10.1016/j.rmr.2010.06.013
16. Schols A. M. W. J., Slangen J., Volovics L., Wouters E. F. M., Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 1998 157 6 1791 1797 2-s2.0-0031862418
17. Landbo C., Prescott E., Lange P., Vestbo J., Almdal T. P., Prognostic value of nutritional status in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 1999 160 6 1856 1861 2-s2.0-0033453187 (Pubitemid 30004687)
18. Marti S., Muñoz X., Rios J., Morell F., Ferrer J. J., Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy. European Respiratory Journal 2006 27 4 689 696 2-s2.0-33750100165 10.1183/09031936.06.00076405 (Pubitemid 44914190)
19. Gray-Donald K., Gibbons L., Shapiro S. H., Macklem P. T., Martin J. G., Nutritional status and mortality in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 1996 153 3 961 966 2-s2.0-0030012047 (Pubitemid 26081646)
20. Marquis K., Debigaré R., Lacasse Y., Leblanc P., Jobin J., Carrier G., Maltais F., Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2002 166 6 809 813 2-s2.0-0037106368 10.1164/rccm.2107031
21. Slinde F., Grönberg A. M., Engström C.-P., Rossander- Hulthén L., Larsson S., Body composition by bioelectrical impedance predicts mortality in chronic obstructive pulmonary disease patients. Respiratory Medicine 2005 99 8 1004 1009 2-s2.0-20444397044 10.1016/j.rmed.2004. 09.024 (Pubitemid 40796543)
22. Chailleux E., Laaban J.-P., Veale D., Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest 2003 123 5 1460 1466 2-s2.0-0037879078 10.1378/chest.123.5.1460 (Pubitemid 36549763)
23. Cano N. J. M., Pichard C., Roth H., Court-Fortuné I., Cynober L., Gérard-Boncompain M., Cuvelier A., Laaban J.-P., Melchior J.-C., Raphaël J.-C., Pison C. M., C-reactive protein and body mass index predict outcome in end-stage respiratory failure. Chest 2004 126 2 540 546 2-s2.0-3242773943 10.1378/chest.126.2.540 (Pubitemid 39093441)
24. Schols A. M. W. J., Broekhuizen R., Weling-Scheepers C. A., Wouters E. F., Body composition and mortality in chronic obstructive pulmonary disease. American Journal of Clinical Nutrition 2005 82 1 53 59 2-s2.0-23444436897 (Pubitemid 41716377)
25. Casaburi R., Bhasin S., Cosentino L., Porszasz J., Somfay A., Lewis M. I., Fournier M., Storer T. W., Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2004 170 8 870 878 2-s2.0-5144228345 10.1164/rccm.200305-617OC (Pubitemid 39346482)
26. Svartberg J., Androgens and chronic obstructive pulmonary disease. Current Opinion in Endocrinology, Diabetes and Obesity 2010 17 3 257 261 2-s2.0-77951863359 10.1097/MED.0b013e3283369da6
27. Jemal A., Ward E., Hao Y., Thun M., Trends in the leading causes of death in the United States, 1970-2002. Journal of the American Medical Association 2005 294 10 1255 1259 2-s2.0-24644439190 10.1001/jama.294.10.1255 (Pubitemid 41352114)
28. O'Donnell D. E., Bertley J. C., Chau L. K. L., Webb K. A., Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. American Journal of Respiratory and Critical Care Medicine 1997 155 1 109 115 2-s2.0-0031027165 (Pubitemid 27053150)
29. Geng T., Li P., Yin X., Yan Z., PGC-1 α promotes nitric oxide antioxidant defenses and inhibits FOXO signaling against cardiac cachexia in mice. American Journal of Pathology 2011 178 4 1738 1748 2-s2.0-79953649622 10.1016/j.ajpath.2011.01.005
30. Jobin J., Maltais F., Doyon J.-F., LeBlanc P., Simard P.-M., Simard A.-A., Simard C., Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. Journal of Cardiopulmonary Rehabilitation 1998 18 6 432 437 2-s2.0-0032414118 10.1097/00008483-199811000- 00005 (Pubitemid 29024891)
31. Drexler H., Riede U., Munzel T., Konig H., Funke E., Just H., Alterations of skeletal muscle in chronic heart failure. Circulation 1992 85 5 1751 1759 2-s2.0-0026589002
32. Lipkin D. P., Jones D. A., Round J. M., Poole-Wilson P. A., Abnormalities of skeletal muscle in patients with chronic heart failure. International Journal of Cardiology 1988 18 2 187 195 2-s2.0-0023832911 (Pubitemid 18016349)
33. Maltais F., Simard A.-A., Simard C., Jobin J., Desgagnés P., LeBlanc P., Janvier R., Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. American Journal of Respiratory and Critical Care Medicine 1996 153 1 288 293 2-s2.0-0030042996 (Pubitemid 26026864)
34. Sauleda J., García-Palmer F., Wiesner R. J., Tarraga S., Harting I., Tomás P., Gómez C., Saus C., Palou A., Agustí A. G. N., Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 1998 157 5, part 1 1413 1417 2-s2.0-17744400902
35. Raguso C. A., Luthy C., Nutritional status in chronic obstructive pulmonary disease: role of hypoxia. Nutrition 2011 27 2 138 143 2-s2.0-78650832689 10.1016/j.nut.2010.07.009
36. Dentener M. A., Creutzberg E. C., Schols A. M. W. J., Mantovani A., Van't Veer C., Buurman W. A., Wouters E. F. M., Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations. Thorax 2001 56 9 721 726 2-s2.0-0034853377 10.1136/thorax.56.9. 721 (Pubitemid 32831700)
37. Eid A. A., Ionescu A. A., Nixon L. S., Lewis-Jenkins V., Matthews S. B., Griffiths T. L., Shale D. J., Inflammatory response and body composition in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2001 164 8 I 1414 1418 2-s2.0-0035888760 (Pubitemid 33124019)
38. Debigaré R., Côté C. H., Maltais F., Peripheral muscle wasting in chronic obstructive pulmonary disease: clinical relevance and mechanisms. American Journal of Respiratory and Critical Care Medicine 2001 164 9 1712 1717 2-s2.0-0035509049 (Pubitemid 33124163)
39. Vermeeren M. A. P., Schols A. M. W. J., Wouters E. F. M., Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD. European Respiratory Journal 1997 10 10 2264 2269 2-s2.0-0030670101 10.1183/09031936.97.10102264 (Pubitemid 27479547)
40. Li P., Waters R. E., Redfern S. I., Zhang M., Mao L., Annex B. H., Yan Z., Oxidative phenotype protects myofibers from pathological insults induced by chronic heart failure in mice. American Journal of Pathology 2007 170 2 599 608 2-s2.0-33947504481 10.2353/ajpath.2007.060505 (Pubitemid 47339397)
41. Spruit M. A., Singh S. J., Garvey C., An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine 2013 188 8 e13 e64
42. Creutzberg E. C., Casaburi R., Endocrinological disturbances in chronic obstructive pulmonary disease. European Respiratory Journal, Supplement 2003 22 46 76s 80s 2-s2.0-1542494099 (Pubitemid 37351739)
43. Laghi F., Antonescu-Turcu A., Collins E., Segal J., Tobin D. E., Jubran A., Tobin M. J., Hypogonadism in men with chronic obstructive pulmonary disease: prevalence and quality of life. American Journal of Respiratory and Critical Care Medicine 2005 171 7 728 733 2-s2.0-16344387528 10.1164/rccm.200501-037OC (Pubitemid 40471143)
44. Debigaré R., Marquis K., Côté C. H., Tremblay R. R., Michaud A., LeBlanc P., Maltais F., Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 2003 124 1 83 89 2-s2.0-0038160013 10.1378/chest.124.1.83 (Pubitemid 36851335)
45. Kamischke A., Kemper D. E., Castel M. A., Lüthke M., Rolf C., Behre H. M., Magnussen H., Nieschlag E., Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. European Respiratory Journal 1998 11 1 41 45 2-s2.0-0031952987 10.1183/09031936.98. 11010041 (Pubitemid 28081793)
46. Wu F. C. W., Tajar A., Beynon J. M., Pye S. R., Silman A. J., Finn J. D., O'Neill T. W., Bartfai G., Casanueva F. F., Forti G., Giwercman A., Han T. S., Kula K., Lean M. E. J., Pendleton N., Punab M., Boonen S., Vanderschueren D., Labrie F., Huhtaniemi I. T., Identification of late-onset hypogonadism in middle-aged and elderly men. The New England Journal of Medicine 2010 363 2 123 135 2-s2.0-77954414397 10.1056/NEJMoa0911101
47. Lapauw B., Goemaere S., Zmierczak H., Pottelbergh I. V., Mahmoud A., Taes Y., De Bacquer D., Vansteelandt S., Kaufman J. M., The decline of serum testosterone levels in community-dwelling men over 70 years of age: descriptive data and predictors of longitudinal changes. European Journal of Endocrinology 2008 159 4 459 468 2-s2.0-54049139949 10.1530/EJE-07-0873
48. Samaras N., Samaras D., Lang P. O., A view of geriatrics through hormones. Maturitas 2012 10.1016/j.maturitas.2012.11.009
49. Aasebo U., Gyltnes A., Bremnes R. M., Aakvaag A., Slordal L., Reversal of sexual impotence in male patients with chronic obstructive pulmonary disease and hypoxemia with long term oxygen therapy. Journal of Steroid Biochemistry and Molecular Biology 1993 46 6 799 803 2-s2.0-0027771135 10.1016/0960-0760(93) 90321-M (Pubitemid 24045147)
50. van der Poll T., Romijn J. A., Endert E., Sauerwein H. P., Effects of tumor necrosis factor on the hypothalamic-pituitary-testicular axis in healthy men. Metabolism 1993 42 3 303 307 2-s2.0-0027518385 10.1016/0026-0495(93)90078-3 (Pubitemid 23073346)
51. Sattler F. R., Castaneda-Sceppa C., Binder E. F., Schroeder E. T., Wang Y., Bhasin S., Kawakubo M., Stewart Y., Yarasheski K. E., Ulloor J., Colletti P., Roubenoff R., Azen S. P., Testosterone and growth hormone improve body composition and muscle performance in older men. Journal of Clinical Endocrinology and Metabolism 2009 94 6 1991 2001 2-s2.0-66749140429 10.1210/jc.2008-2338
52. Serra C., Bhasin S., Tangherlini F., Barton E. R., Ganno M., Zhang A., Shansky J., Vandenburgh H. H., Travison T. G., Jasuja R., Morris C., The role of GH and IGF-I in mediating anabolic effects of testosterone on androgen-responsive muscle. Endocrinology 2011 152 1 193 206 2-s2.0-78650810413 10.1210/en.2010-0802
53. Storer T. W., Woodhouse L., Magliano L., Singh A. B., Dzekov C., Dzekov J., Bhasin S., Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men. Journal of the American Geriatrics Society 2008 56 11 1991 1999 2-s2.0-55349088602 10.1111/j.1532-5415.2008.01927.x
54. Maggio M., Ceda G. P., Lauretani F., Bandinelli S., Metter E. J., Guralnik J. M., Basaria S., Cattabiani C., Luci M., Dall'Aglio E., Vignali A., Volpi R., Valenti G., Ferrucci L., Gonadal status and physical performance in older men. Aging Male 2011 14 1 42 47 2-s2.0-79751469516 10.3109/13685538.2010. 518179
55. O'Connell M. D. L., Tajar A., Roberts S. A., Wu F. C. W., Do androgens play any role in the physical frailty of ageing men? International Journal of Andrology 2011 34 3 195 211 2-s2.0-79955604878 10.1111/j.1365-2605.2010.01093.x
56. Van Vliet M., Spruit M. A., Verleden G., Kasran A., Van Herck E., Pitta F., Bouillon R., Decramer M., Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2005 172 9 1105 1111 2-s2.0-30344434370 10.1164/rccm.200501-114OC (Pubitemid 43066645)
57. Hyde Z., Norman P. E., Flicker L., Hankey G. J., Almeida O. P., McCaul K. A., Chubb S. A. P., Yeap B. B., Low free testosterone predicts mortality from cardiovascular disease but not other causes: the health in men study. Journal of Clinical Endocrinology and Metabolism 2012 97 1 179 189 2-s2.0-84855509183 10.1210/jc.2011-1617
58. Oettel M., Hübler D., Patchev V., Selected aspects of endocrine pharmacology of the aging male. Experimental Gerontology 2003 38 1-2 189 198 2-s2.0-0037237890 10.1016/S0531-5565(02)00185-7 (Pubitemid 36110513)
59. Scalvini S., Plasma hormone levels and haemodynamics in patients with chronic obstructive lung disease. Monaldi Archives for Chest Disease 1996 51 5 380 386 2-s2.0-0030497932 (Pubitemid 27062781)
60. Hjalmarsen A., Aasebø U., Birkeland K., Sager G., Jorde R., Impaired glucose tolerance in patients with chronic hypoxic pulmonary disease. Diabetes and Metabolism 1996 22 1 37 42 2-s2.0-0029665733
61. Srinivas-Shankar U., Roberts S. A., Connolly M. J., O'Connell M. D. L., Adams J. E., Oldham J. A., Wu F. C. W., Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 2010 95 2 639 650 2-s2.0-76149135996 10.1210/jc.2009-1251
62. Emmelot-Vonk M. H., Verhaar H. J. J., Nakhai Pour H. R., Aleman A., Lock T. M. T. W., Bosch J. L. H. R., Grobbee D. E., Van Der Schouw Y. T., Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. Journal of the American Medical Association 2008 299 1 39 52 2-s2.0-38049005469 10.1001/jama.2007.51
63. Basaria S., Coviello A. D., Travison T. G., Storer T. W., Farwell W. R., Jette A. M., Eder R., Tennstedt S., Ulloor J., Zhang A., Choong K., Lakshman K. M., Mazer N. A., Miciek R., Krasnoff J., Elmi A., Knapp P. E., Brooks B., Appleman E., Aggarwal S., Bhasin G., Hede-Brierley L., Bhatia A., Collins L., LeBrasseur N., Fiore L. D., Bhasin S., Adverse events associated with testosterone administration. The New England Journal of Medicine 2010 363 2 109 122 2-s2.0-77954421915 10.1056/NEJMoa1000485
64. Ottenbacher K. J., Ottenbacher M. E., Ottenbacher A. J., Acha A. A., Ostir G. V., Androgen treatment and muscle strength in elderly men: a meta-analysis. Journal of the American Geriatrics Society 2006 54 11 1666 1673 2-s2.0-33750518404 10.1111/j.1532-5415.2006.00938.x (Pubitemid 44665204)
65. Travison T. G., Basaria S., Storer T. W., Jette A. M., Miciek R., Farwell W. R., Choong K., Lakshman K., Mazer N. A., Coviello A. D., Knapp P. E., Ulloor J., Zhang A., Brooks B., Nguyen A.-H., Eder R., Lebrasseur N., Elmi A., Appleman E., Hede-Brierley L., Bhasin G., Bhatia A., Lazzari A., Davis S., Ni P., Collins L., Bhasin S., Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation. Journals of Gerontology A 2011 66 10 1090 1099 2-s2.0-80052912002 10.1093/gerona/glr100
66. Araujo A. B., Travison T. G., Bhasin S., Esche G. R., Williams R. E., Clark R. V., McKinlay J. B., Association between testosterone and estradiol and age-related decline in physical function in a diverse sample of men. Journal of the American Geriatrics Society 2008 56 11 2000 2008 2-s2.0-55349123630 10.1111/j.1532-5415.2008.01965.x
67. Velema M. S., Kwa B. H. B., De Ronde W., Should androgenic anabolic steroids be considered in the treatment regime of selected chronic obstructive pulmonary disease patients? Current Opinion in Pulmonary Medicine 2012 18 2 118 124 2-s2.0-84856665284 10.1097/MCP.0b013e32834e9001
68. Yeh S.-S., DeGuzman B., Kramer T., Reversal of COPD-associated weight loss using the anabolic agent oxandrolone. Chest 2002 122 2 421 428 2-s2.0-0036036456 10.1378/chest.122.2.421 (Pubitemid 35002116)
69. Svartberg J., Aaseboø U., Hjalmarsen A., Sundsfjord J., Jorde R., Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial. Respiratory Medicine 2004 98 9 906 913 2-s2.0-4043104928 10.1016/j.rmed.2004.02.015 (Pubitemid 39069342)
70. Schols A. M. W. J., Soeters P. B., Mostert R., Pluymers R. J., Wouters E. F. M., Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease: a placebo-controlled randomized trial. American Journal of Respiratory and Critical Care Medicine 1995 152 4, part 1 1268 1274 2-s2.0-0029118877
71. Ferreira I. M., Verreschi I. T., Nery L. E., Goldstein R. S., Zamel N., Brooks D., Jardim J. R., The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest 1998 114 1 19 28 2-s2.0-0031817306 (Pubitemid 28337356)
72. Pison C. M., Cano N. J., Chérion C., Caron F., Court-Fortune I., Antonini M.-T., Gonzalez-Bermejo J., Meziane L., Molano L. C., Janssens J.-P., Costes F., Wuyam B., Similowski T., Melloni B., Hayot M., Augustin J., Tardif C., Lejeune H., Roth H., Pichard C., Maclet E., Vivodtzev I., Guzun R., Abry D., Henquin N., Cracowski J. L., Putod F., Borel J. C., Michallet A. S., Meurice J. C., Adoun M. L., Januel B., Charles M., Desport J. C., Ribardière J. M., Dalmay F., Samptiaux P., Arnold V., Dzugan P., Marchaisseau E., Jeandeau S., Triki H., Godard P., Préfaut C., Straus C., Dalmolin E., Cornu E., Cuvelier A., Muir J. F., Dupuis J., Lombard C., Claustrat B., Touraine F., Multimodal nutritional rehabilitation improves clinical outcomes of malnourished patients with chronic respiratory failure: a randomised controlled trial. Thorax 2011 66 11 953 960 2-s2.0-80054124020 10.1136/thx.2010.154922
73. Bolton C. E., Bevan-Smith E. F., Blakey J. D., British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax 2013 10.1136/thoraxjnl-2013-203808
74. Lacasse Y., Martin S., Lasserson T. J., Goldstein R. S., Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease a Cochrane systematic review. Europa Medicophysica 2007 43 4 475 485 2-s2.0-39049127974
75. Ries A. L., Bauldoff G. S., Carlin B. W., Casaburi R., Emery C. F., Mahler D. A., Make B., Rochester C. L., ZuWallack R., Herrerias C., Pulmonary rehabilitation: joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 2007 131 5, supplement 4S 42S 2-s2.0-34248371116 10.1378/chest.06-2418 (Pubitemid 46744215)
76. Vogiatzis I., Strategies of muscle training in very severe COPD patients. European Respiratory Journal 2011 38 4 971 975 2-s2.0-80053080348 10.1183/09031936.00075011
77. Vivodtzev I., Pépin J.-L., Vottero G., Mayer V., Porsin B., Lévy P., Wuyam B., Improvement in quadriceps strenght and dyspnea in daily tasks after 1 month of electrical stimulation in severely deconditioned and malnourished COPD. Chest 2006 129 6 1540 1548 2-s2.0-33745121586 10.1378/chest.129.6.1540 (Pubitemid 43894983)
78. Anker S. D., Coats A. J. S., Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 1999 115 3 836 847 2-s2.0-0033035459 10.1378/chest.115.3.836 (Pubitemid 29129969)
79. Lenk K., Schur R., Linke A., Erbs S., Matsumoto Y., Adams V., Schuler G., Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model. European Journal of Heart Failure 2009 11 4 342 348 2-s2.0-66249091925 10.1093/eurjhf/hfp020
80. Héliès-Toussaint C., Moinard C., Rasmusen C., Tabbi-Anneni I., Cynober L., Grynberg A., Aortic banding in rat as a model to investigate malnutrition associated with heart failure. American Journal of Physiology 2005 288 5 R1325 R1331 2-s2.0-17844377954 10.1152/ajpregu.00320.2004 (Pubitemid 40593717)
81. Guerrero K., Wuyam B., Mezin P., Vivodtzev I., Vendelin M., Borel J.-C., Hacini R., Chavanon O., Imbeaud S., Saks V., Pison C., Functional coupling of adenine nucleotide translocase and mitochondrial creatine kinase is enhanced after exercise training in lung transplant skeletal muscle. American Journal of Physiology 2005 289 4 R1144 R1154 2-s2.0-25844485912 10.1152/ajpregu.00229.2005 (Pubitemid 41397065)
82. van den Ham E. C. H., Kooman J. P., Schols A. M. W. J., Nieman F. H. M., Does J. D., Akkermans M. A., Janssen P. P., Gosker H. R., Ward K. A., MacDonald J. H., Christiaans M. H. L., Leunissen K. M. L., Van Hooff J. P., The functional, metabolic, and anabolic responses to exercise training in renal transplant and hemodialysis patients. Transplantation 2007 83 8 1059 1068 2-s2.0-34247515195 10.1097/01.tp.0000259552.55689.fd (Pubitemid 46659118)
83. Samaras N., Samaras D., Lang P. O., Chronic obstructive pulmonary disease: risk and benefit of testosterone therapy. Revue Médicale Suisse 2012 8 363 2224 2227
84. Samaras N., Frangos E., Forster A., Graf C., Samaras D., Back pain: a case of ivory vertebrae and ribs. European Geriatric Medicine 2012 3 3 184 185 2-s2.0-84857314280 10.1016/j.eurger.2012.01.016